Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04421820
Title BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bold Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | IRL | CAN

Facility Status City State Zip Country Details
University of California, Los Angeles RECRUITING Santa Monica California 90095 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Cross Cancer Institue RECRUITING Edmonton Alberta Canada Details
Juravinski Cancer Centre RECRUITING Hamilton Ontario Canada Details
The Ottawa Hospital Cancer Centre RECRUITING Ottawa Ontario Canada Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario Canada Details
Jewish General Hospital RECRUITING Montreal Quebec Canada Details
McGill University Health Centre Glen Site RECRUITING Montréal Quebec Canada Details
St. James Hospital RECRUITING Dublin Ireland Details
National Cancer Center RECRUITING Goyang Korea, Republic of Details
Kangbuk Samsung Hospital RECRUITING Seoul Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul Korea, Republic of Details
Severance Hospital - Yonsei University RECRUITING Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field